Abstract | BACKGROUND AND OBJECTIVES: DESIGN AND METHODS: A total of 23 patients who underwent BM biopsy for routine pre-therapeutic evaluation were enrolled in the study. We used EBER-1 ISH to investigate the expression of EBER-1 in 30 BM specimens. The clinical correlation and therapeutic outcomes of these patients were analyzed. In addition, genomic analysis of EBV was performed in five patients. RESULTS: Conventional morphologic examinations failed to identify any lymphoma involvement in the 23 BM specimens obtained at initial staging. However, 10 of the 23 BM were positive for EBER-1. A lower survival rate was seen in patients with BM positive for EBER-1. Only the BM EBER-1 ISH result was shown to be an independent variable predicting overall survival in stage I and II patients (p=0.027; hazard ratio for death 0.066, 95% confidence interval, 0.006 to 0.733), suggesting that EBER-1 positivity in BM is the major determinant of a poor prognosis. However, discrepancies in the EBV strains between the primary tumor and BM existed in two of the five studied patients. INTERPRETATION AND CONCLUSIONS: We suggest that EBER-1 ISH should be performed on BM specimens of patients with nasal NK/ T-cell lymphoma to identify the presence of EBER-1 positive cells, which appears to carry a poor prognosis. Whether or not the EBER-1 positive cells in the BM of nasal NK/ T-cell lymphoma patients are true tumor cells requires further study.
|
Authors | Wen-Tsung Huang, Kun-Chao Chang, Guan-Cheng Huang, Jenn-Ren Hsiao, Helen-H W Chen, Shih-Sung Chuang, Tsai-Yun Chen, Wu-Chou Su, Chao-Jung Tsao |
Journal | Haematologica
(Haematologica)
Vol. 90
Issue 8
Pg. 1063-9
(Aug 2005)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 16079105
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA Primers
- Epstein-Barr virus encoded RNA 1
- RNA, Viral
|
Topics |
- Adult
- Aged
- Bone Marrow Cells
(pathology, virology)
- DNA Primers
- Female
- Herpesvirus 4, Human
(genetics, isolation & purification)
- Humans
- In Situ Hybridization
- Killer Cells, Natural
(immunology)
- Lymphoma, T-Cell
(immunology, mortality, pathology)
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- RNA, Viral
(genetics)
- Retrospective Studies
- Survival Analysis
|